Regulatory Affairs Outsourcing Market Report
RA08205
Regulatory Affairs Outsourcing Market by Service (Regulatory Consulting, Legal Representation, Regulatory Writing & Publishing, Product Registration & Clinical Trial Applications, Regulatory Submission, Regulatory Operations, and Other Services), Company Size (Small, Medium, and Large), Category (Pharmaceuticals and Medical Device), Indication (Oncology, Neurology, Cardiology, Immunology, and Others), Stages (Preclinical, Clinical, and Post Market Authorization (PMA)), End-Use (Medical Device Companies, Pharmaceutical Companies, and Biotechnology Companies), and Region (North America, Europe, Asia-Pacific, and LAMEA): Opportunity Analysis and Industry Forecast, 2023-2032
Regulatory Affairs Outsourcing Overview
Regulatory affairs outsourcing involves delegating regulatory activities and responsibilities to external organizations or consultants. It is commonly practiced in the life sciences and healthcare industries, where regulatory compliance is crucial. Companies can benefit from their expertise and streamline regulatory processes by outsourcing regulatory affairs functions to specialized firms or consultants. These outsourcing partners possess deep knowledge of the regulatory landscape and can navigate complex requirements efficiently. They assist companies in developing regulatory strategies, preparing and submitting regulatory submissions, and managing interactions with regulatory authorities. Outsourcing regulatory affairs offers advantages, such as access to specialized expertise, cost efficiencies, faster time-to-market, reduced regulatory risks, and the ability to scale resources as needed.
Global Regulatory Affairs Outsourcing Market Analysis
The global regulatory affairs outsourcing market size was $7.02 billion in 2022 and is predicted to grow with a CAGR of 8.4%, by generating a revenue of $14.88 billion by 2032.
COVID-19 Impact on Global Regulatory Affairs Outsourcing Market
The COVID-19 pandemic has profoundly impacted the regulatory affairs outsourcing market. The increased demand for healthcare products, such as vaccines and therapeutic drugs, has increased the need for regulatory expertise. Companies have turned to outsourcing firms to navigate the complex regulatory landscape and expedite product approvals. The pandemic has also prompted regulatory agencies to introduce new guidelines and regulations, requiring businesses to stay updated and adapt their strategies accordingly. Remote working and digitization have become the norm, with outsourcing firms investing in technology infrastructure to ensure secure data exchange. Delays in regulatory processes have occurred due to reduced staff availability and prioritization of COVID-19-related activities.
However, the crisis has also brought opportunities for outsourcing companies specializing in vaccine development and COVID-19 diagnostics. As the world continues to address the pandemic and prepare for future challenges, the regulatory affairs outsourcing market is expected to grow, emphasizing the importance of risk assessment and mitigation in the healthcare sector.
Increasing Regulatory Complexity to Drive the Market Growth
The regulatory affairs outsourcing market is driven by various factors contributing to its growth and demand. Firstly, the increasing complexity of regulations across industries necessitates specialized expertise to navigate the intricacies effectively. Companies find it challenging to keep up with evolving requirements, leading them to outsource regulatory affairs. Secondly, outsourcing offers cost-saving advantages as maintaining an in-house regulatory affairs team requires significant resource investment. Additionally, by outsourcing, companies can reduce overhead costs associated with specialized personnel. Additionally, access to a pool of experts with in-depth knowledge and experience in regulatory compliance is a significant driver. These experts are well-versed in local regulations and global standards, enabling efficient navigation through diverse regulatory frameworks. Furthermore, global market expansion drives outsourcing as companies need assistance obtaining approvals, registrations, and licenses to comply with regional requirements.
Data Privacy and Security to Restrain the Market Growth
The growth of the regulatory affairs outsourcing market can be restrained by various factors. One significant factor is data privacy and security. Regulatory affairs outsourcing involves sharing sensitive data and information with external service providers. Companies may have concerns about data privacy, security breaches, and compliance with data protection regulations, such as the General Data Protection Regulation (GDPR). These concerns can act as a restraint on outsourcing activities. Intellectual property (IP) protection concerns also play a role, as companies may hesitate to share confidential information with external providers. Maintaining quality and regulatory compliance is crucial, and if companies perceive significant risks in outsourcing these activities, they may opt for in-house solutions instead. Communication and collaboration challenges can impact effective partnerships, including language barriers and cultural differences.
Globalization and Market Expansion to Drive Excellent Opportunities
The regulatory affairs outsourcing market benefits from several key factors that create opportunities for its growth. Globalization and market expansion drive the demand for regulatory support in different countries. Outsourcing enables companies to access local knowledge and expertise, ensuring compliance with regional regulations and facilitating market entry. Besides, globalization and market expansion drive the demand for regulatory support in different countries. Outsourcing enables companies to access local knowledge and expertise, ensuring compliance with regional regulations and facilitating market entry. Additionally, cost optimization is a significant driver as outsourcing can offer cost advantages compared to maintaining an in-house regulatory affairs department. This allows companies to reduce operational costs and focus on their core competencies.
Global Regulatory Affairs Outsourcing Market Share, by Service, 2022
The product registration & clinical trial applications sub-segment accounted for the highest market share in 2022. Product registration and clinical trial applications have emerged as significant drivers in the dominance of the regulatory affairs outsourcing market. This market focuses on ensuring compliance with regulatory authorities' guidelines for healthcare products, including pharmaceuticals and medical devices. Outsourcing regulatory affairs functions has become increasingly popular due to the complexities involved and the need for specialized expertise. Product registration and clinical trial applications require in-depth knowledge of regulations and submission processes. By outsourcing these tasks, companies gain access to professionals with expertise in navigating regulatory landscapes and meeting specific regional requirements.
Global Regulatory Affairs Outsourcing Market Share, by Company Size, 2022
The large sub-segment accounted for the highest market share in 2022. Large companies can dominate through various strategies in the regulatory affairs outsourcing market. One key factor is market positioning. Clients often prefer established companies with solid reputations and brand recognition. Additionally, larger companies possess extensive resources, such as a larger workforce, financial capabilities, and infrastructure, allowing them to offer a broader range of services and attract top talent. Their global reach, with offices and operations in multiple countries, enables them to cater to clients worldwide and understand local regulatory requirements.
Global Regulatory Affairs Outsourcing Market Share, by Category, 2022
The pharmaceuticals sub-segment accounted for the highest market share in 2022. Pharmaceutical companies have dominated the regulatory affairs outsourcing market due to various reasons. The industry operates in a complex regulatory environment with numerous laws and guidelines challenging compliance. Outsourcing regulatory affairs tasks helps companies navigate these complexities more efficiently. By accessing the expertise and knowledge of regulatory professionals, pharmaceutical firms can ensure compliance and expedite product approval. Additionally, outsourcing provides cost optimization by reducing overhead expenses associated with maintaining an in-house regulatory department. The global reach of pharmaceutical companies is also facilitated through outsourcing, as they can leverage established networks and the local knowledge of outsourcing partners.
Global Regulatory Affairs Outsourcing Market Share, by Indication, 2022
The oncology sub-segment accounted for the highest market share in 2022. Oncology has emerged as a dominant force in the regulatory affairs outsourcing market due to several key factors. The complex regulatory landscape surrounding cancer treatments requires specialized knowledge and expertise to navigate effectively. With the rapid advancements in cancer research and the introduction of personalized medicine, regulatory compliance in oncology has become increasingly intricate. By outsourcing regulatory affairs, pharmaceutical and biotechnology companies can tap into the specialized knowledge of external firms to streamline their processes and ensure compliance with the stringent requirements imposed by regulatory authorities. Additionally, the global presence of cancer as a health concern necessitates companies to navigate multiple regulatory frameworks simultaneously. This makes regulatory affairs outsourcing firms with a worldwide footprint invaluable in accelerating market entry for oncology products.
Global Regulatory Affairs Outsourcing Market Share, by Stage, 2022
The clinical sub-segment accounted for the highest market share in 2022. Clinical Research Organizations (CROs) have dominated the regulatory affairs outsourcing market due to several key factors. These specialized companies offer expertise in conducting clinical trials, managing regulatory affairs, and navigating the complex regulatory landscape. CROs have deep knowledge and experience in regulatory requirements across various jurisdictions, making them valuable partners for companies seeking regulatory support. Outsourcing regulatory affairs to CROs provides flexibility and cost-effectiveness, as companies can access specialized resources without needing a dedicated in-house team. CROs also ensure regulatory compliance through established processes and systems, helping companies meet requirements efficiently.
Global Regulatory Affairs Outsourcing Market Share, by End-Use, 2022
The pharmaceuticals companies sub-segment accounted for the highest market share in 2022. Pharmaceutical companies have played a significant role in the dominance of the regulatory affairs outsourcing market. These companies operate within a highly regulated environment, facing complex processes and regulations for drug development and commercialization. As regulations evolve and become more intricate, pharmaceutical companies often struggle to keep up. Thus, they turn to external expertise through regulatory affairs outsourcing. By outsourcing these functions to specialized service providers, pharmaceutical companies can streamline operations, reduce costs, and accelerate the regulatory approval process. This approach allows them to focus on their core competencies while benefiting from outsourcing partners' specialized knowledge and experience.
Global Regulatory Affairs Outsourcing Market Share, by Region, 2022
The Asia-Pacific regulatory affairs outsourcing market generated the highest revenue in 2022. The dominance of the Asia-Pacific region in the regulatory outsourcing market can be attributed to several key factors. Countries like India, China and the Philippines have significant cost advantages as they have a large pool of skilled professionals who can give regulatory services at a lower cost than developed countries. Moreover, the region encompasses a well-trained workforce with expertise in regulatory matters thanks to investments in education and training programs focused on pharmaceuticals and life sciences. Furthermore, the presence of robust regulatory frameworks and agencies in many Asian countries has fostered a deep understanding of regulatory processes and requirements, making the region an ideal destination for outsourcing. The Asia-Pacific region has also seen substantial growth in the pharmaceutical and life sciences industries, which has driven the demand for regulatory affairs services and boosted the outsourcing market.
Competitive Scenario in the Global Regulatory Affairs Outsourcing Market
Investment and agreement are common strategies followed by major market players. One of the leading market players in the industry is ICON plc. In July 2021, ICON plc acquired PRA Health Sciences, a CRO providing drug development and regulatory advisory services. The purpose of this acquisition was to expand ICON plc's service portfolio.
Some of the leading regulatory affairs outsourcing market players are Accell Clinical Research, LLC, Genpact, CRITERIUM, INC, Promedica International, WuXi AppTec, Medpace, Charles River Laboratories, ICON plc, Covance, Inc. (Labcorp Drug Development), Parexel International Corporation, Freyr and PHARMALEX GMBH.
| Aspect | Particulars |
| Historical Market Estimations | 2020-2022 |
| Base Year for Market Estimation | 2022 |
| Forecast Timeline for Market Projection | 2023-2032 |
| Geographical Scope | North America, Europe, Asia-Pacific, and LAMEA |
| Segmentation by Service |
|
| Segmentation by Company Size |
|
|
Segmentation by Category
|
|
| Segmentation by Indication |
|
| Segmentation by Stage |
|
| Segmentation by End-Use |
|
| Key Companies Profiled |
|
Q1. What is the size of the global regulatory affairs outsourcing market?
A. The size of the global regulatory affairs outsourcing market was over $7.02 billion in 2022 and is projected to reach $14.88 billion by 2032.
Q2. Which are the major companies in the regulatory affairs outsourcing market?
A. Freyr and PHARMALEX GMBH are some of the key players in the global regulatory affairs outsourcing market.
Q3. Which region, among others, possesses greater investment opportunities in the near future?
A. The Asia-Pacific region possesses great investment opportunities for investors to witness the most promising growth in the future.
Q4. What are the strategies opted by the leading players in this market?
A. Agreement and investment are the two key strategies opted by the operating companies in this market.
Q5. Which companies are investing more on R&D practices?
A. Promedica International, WuXi AppTec, Medpace, Charles River Laboratories, and ICON plc are the companies investing more on R&D activities.
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Regulatory Affairs Outsourcing Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Regulatory Affairs Outsourcing Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Regulatory Affairs Outsourcing Market, By Product
5.1. Overview
5.2 Drugs
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Generics
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Innovators
5.4.1 Definition, key trends, growth factors, and opportunities
5.4.2 Market size analysis, by region, 2020-2027
5.4.3 Market share analysis, by country, 2020-2027
5.5 Biologics
5.5.1 Definition, key trends, growth factors, and opportunities
5.5.2 Market size analysis, by region, 2020-2027
5.5.3 Market share analysis, by country, 2020-2027
5.6 Biotech
5.6.1 Definition, key trends, growth factors, and opportunities
5.6.2 Market size analysis, by region, 2020-2027
5.6.3 Market share analysis, by country, 2020-2027
5.7 ATMPs
5.7.1 Definition, key trends, growth factors, and opportunities
5.7.2 Market size analysis, by region, 2020-2027
5.7.3 Market share analysis, by country, 2020-2027
5.8 Medical devices
5.8.1 Definition, key trends, growth factors, and opportunities
5.8.2 Market size analysis, by region, 2020-2027
5.8.3 Market share analysis, by country, 2020-2027
5.9 Therapeutic
5.9.1 Definition, key trends, growth factors, and opportunities
5.9.2 Market size analysis, by region, 2020-2027
5.9.3 Market share analysis, by country, 2020-2027
5.10 Diagnostic
5.10.1 Definition, key trends, growth factors, and opportunities
5.10.2 Market size analysis, by region, 2020-2027
5.10.3 Market share analysis, by country, 2020-2027
5.11 Research Dive Exclusive Insights
5.11.1 Market attractiveness
5.11.2 Competition heatmap
-
6. Regulatory Affairs Outsourcing Market, By Type
6.1. Overview
6.2 Oncology
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 Neurology
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Cardiology
6.4.1 Definition, key trends, growth factors, and opportunities
6.4.2 Market size analysis, by region, 2020-2027
6.4.3 Market share analysis, by country, 2020-2027
6.5 Immunology
6.5.1 Definition, key trends, growth factors, and opportunities
6.5.2 Market size analysis, by region, 2020-2027
6.5.3 Market share analysis, by country, 2020-2027
6.6 Others
6.6.1 Definition, key trends, growth factors, and opportunities
6.6.2 Market size analysis, by region, 2020-2027
6.6.3 Market share analysis, by country, 2020-2027
6.7 Research Dive Exclusive Insights
6.7.1 Market attractiveness
6.7.2 Competition heatmap
-
7. Regulatory Affairs Outsourcing Market, By Deployment
7.1. Overview
7.2 Medical Device Companies
7.2.1 Definition, key trends, growth factors, and opportunities
7.2.2 Market size analysis, by region, 2020-2027
7.2.3 Market share analysis, by country, 2020-2027
7.3 Pharmaceutical Companies
7.3.1 Definition, key trends, growth factors, and opportunities
7.3.2 Market size analysis, by region, 2020-2027
7.3.3 Market share analysis, by country, 2020-2027
7.4 Biotechnology Companies
7.4.1 Definition, key trends, growth factors, and opportunities
7.4.2 Market size analysis, by region, 2020-2027
7.4.3 Market share analysis, by country, 2020-2027
7.5 Research Dive Exclusive Insights
7.5.1 Market attractiveness
7.5.2 Competition heatmap
-
8. Regulatory Affairs Outsourcing Market, By Solution
8.1. Overview
8.2 Regulatory Consulting
8.2.1 Definition, key trends, growth factors, and opportunities
8.2.2 Market size analysis, by region, 2020-2027
8.2.3 Market share analysis, by country, 2020-2027
8.3 Legal Representation
8.3.1 Definition, key trends, growth factors, and opportunities
8.3.2 Market size analysis, by region, 2020-2027
8.3.3 Market share analysis, by country, 2020-2027
8.4 Regulatory Writing & Publishing
8.4.1 Definition, key trends, growth factors, and opportunities
8.4.2 Market size analysis, by region, 2020-2027
8.4.3 Market share analysis, by country, 2020-2027
8.5 Product Registration & Clinical Trial Applications
8.5.1 Definition, key trends, growth factors, and opportunities
8.5.2 Market size analysis, by region, 2020-2027
8.5.3 Market share analysis, by country, 2020-2027
8.6 Other Services
8.6.1 Definition, key trends, growth factors, and opportunities
8.6.2 Market size analysis, by region, 2020-2027
8.6.3 Market share analysis, by country, 2020-2027
8.7 Research Dive Exclusive Insights
8.7.1 Market attractiveness
8.7.2 Competition heatmap
-
9. Regulatory Affairs Outsourcing Market, By Function
9.1. Overview
9.2 Small
9.2.1 Definition, key trends, growth factors, and opportunities
9.2.2 Market size analysis, by region, 2020-2027
9.2.3 Market share analysis, by country, 2020-2027
9.3 Medium
9.3.1 Definition, key trends, growth factors, and opportunities
9.3.2 Market size analysis, by region, 2020-2027
9.3.3 Market share analysis, by country, 2020-2027
9.4 Large
9.4.1 Definition, key trends, growth factors, and opportunities
9.4.2 Market size analysis, by region, 2020-2027
9.4.3 Market share analysis, by country, 2020-2027
9.5 Research Dive Exclusive Insights
9.5.1 Market attractiveness
9.5.2 Competition heatmap
10. Regulatory Affairs Outsourcing Market, By Region
10.1 North America
10.1.1 U.S
10.1.1.1 Market size analysis, By Product, 2020-2027
10.1.1.2 Market size analysis, By Type, 2020-2027
10.1.1.3 Market size analysis, By Deployment, 2020-2027
10.1.1.4 Market size analysis, By Solution, 2020-2027
10.1.1.5 Market size analysis, By Function, 2020-2027
10.1.2 Canada
10.1.2.1 Market size analysis, By Product, 2020-2027
10.1.2.2 Market size analysis, By Type, 2020-2027
10.1.2.3 Market size analysis, By Deployment, 2020-2027
10.1.2.4 Market size analysis, By Solution, 2020-2027
10.1.2.5 Market size analysis, By Function, 2020-2027
10.1.3 Mexico
10.1.3.1 Market size analysis, By Product, 2020-2027
10.1.3.2 Market size analysis, By Type, 2020-2027
10.1.3.3 Market size analysis, By Deployment, 2020-2027
10.1.3.4 Market size analysis, By Solution, 2020-2027
10.1.3.5 Market size analysis, By Function, 2020-2027
10.1.4 Research Dive Exclusive Insights
10.1.4.1 Market attractiveness
10.1.4.2 Competition heatmap
10.2 Europe
10.2.1 Germany
10.2.1.1 Market size analysis, By Product, 2020-2027
10.2.1.2 Market size analysis, By Type, 2020-2027
10.2.1.3 Market size analysis, By Deployment, 2020-2027
10.2.1.4 Market size analysis, By Solution, 2020-2027
10.2.1.5 Market size analysis, By Function, 2020-2027
10.2.2 UK
10.2.2.1 Market size analysis, By Product, 2020-2027
10.2.2.2 Market size analysis, By Type, 2020-2027
10.2.2.3 Market size analysis, By Deployment, 2020-2027
10.2.2.4 Market size analysis, By Solution, 2020-2027
10.2.2.5 Market size analysis, By Function, 2020-2027
10.2.3 France
10.2.3.1 Market size analysis, By Product, 2020-2027
10.2.3.2 Market size analysis, By Type, 2020-2027
10.2.3.3 Market size analysis, By Deployment, 2020-2027
10.2.3.4 Market size analysis, By Solution, 2020-2027
10.2.3.5 Market size analysis, By Function, 2020-2027
10.2.4 Spain
10.2.4.1 Market size analysis, By Product, 2020-2027
10.2.4.2 Market size analysis, By Type, 2020-2027
10.2.4.3 Market size analysis, By Deployment, 2020-2027
10.2.4.4 Market size analysis, By Solution, 2020-2027
10.2.4.5 Market size analysis, By Function, 2020-2027
10.2.5 Italy
10.2.5.1 Market size analysis, By Product, 2020-2027
10.2.5.2 Market size analysis, By Type, 2020-2027
10.2.5.3 Market size analysis, By Deployment, 2020-2027
10.2.5.4 Market size analysis, By Solution, 2020-2027
10.2.5.5 Market size analysis, By Function, 2020-2027
10.2.6 Rest of Europe
10.2.6.1 Market size analysis, By Product, 2020-2027
10.2.6.2 Market size analysis, By Type, 2020-2027
10.2.6.3 Market size analysis, By Deployment, 2020-2027
10.2.6.4 Market size analysis, By Solution, 2020-2027
10.2.6.5 Market size analysis, By Function, 2020-2027
10.2.7 Research Dive Exclusive Insights
10.2.7.1 Market attractiveness
10.2.7.2 Competition heatmap
10.3 Asia-Pacific
10.3.1 China
10.3.1.1 Market size analysis, By Product, 2020-2027
10.3.1.2 Market size analysis, By Type, 2020-2027
10.3.1.3 Market size analysis, By Deployment, 2020-2027
10.3.1.4 Market size analysis, By Solution, 2020-2027
10.3.1.5 Market size analysis, By Function, 2020-2027
10.3.2 Japan
10.3.2.1 Market size analysis, By Product, 2020-2027
10.3.2.2 Market size analysis, By Type, 2020-2027
10.3.2.3 Market size analysis, By Deployment, 2020-2027
10.3.2.4 Market size analysis, By Solution, 2020-2027
10.3.2.5 Market size analysis, By Function, 2020-2027
10.3.3 India
10.3.3.1 Market size analysis, By Product, 2020-2027
10.3.3.2 Market size analysis, By Type, 2020-2027
10.3.3.3 Market size analysis, By Deployment, 2020-2027
10.3.3.4 Market size analysis, By Solution, 2020-2027
10.3.3.5 Market size analysis, By Function, 2020-2027
10.3.4 Australia
10.3.4.1 Market size analysis, By Product, 2020-2027
10.3.4.2 Market size analysis, By Type, 2020-2027
10.3.4.3 Market size analysis, By Deployment, 2020-2027
10.3.4.4 Market size analysis, By Solution, 2020-2027
10.3.4.5 Market size analysis, By Function, 2020-2027
10.3.5 South Korea
10.3.5.1 Market size analysis, By Product, 2020-2027
10.3.5.2 Market size analysis, By Type, 2020-2027
10.3.5.3 Market size analysis, By Deployment, 2020-2027
10.3.5.4 Market size analysis, By Solution, 2020-2027
10.3.5.5 Market size analysis, By Function, 2020-2027
10.3.6 Rest of Asia-Pacific
10.3.6.1 Market size analysis, By Product, 2020-2027
10.3.6.2 Market size analysis, By Type, 2020-2027
10.3.6.3 Market size analysis, By Deployment, 2020-2027
10.3.6.4 Market size analysis, By Solution, 2020-2027
10.3.6.5 Market size analysis, By Function, 2020-2027
10.3.7 Research Dive Exclusive Insights
10.3.7.1 Market attractiveness
10.3.7.2 Competition heatmap
10.4 LAMEA
10.4.1 Brazil
10.4.1.1 Market size analysis, By Product, 2020-2027
10.4.1.2 Market size analysis, By Type, 2020-2027
10.4.1.3 Market size analysis, By Deployment, 2020-2027
10.4.1.4 Market size analysis, By Solution, 2020-2027
10.4.1.5 Market size analysis, By Function, 2020-2027
10.4.2 Saudi Arabia
10.4.2.1 Market size analysis, By Product, 2020-2027
10.4.2.2 Market size analysis, By Type, 2020-2027
10.4.2.3 Market size analysis, By Deployment, 2020-2027
10.4.2.4 Market size analysis, By Solution, 2020-2027
10.4.2.5 Market size analysis, By Function, 2020-2027
10.4.3 UAE
10.4.3.1 Market size analysis, By Product, 2020-2027
10.4.3.2 Market size analysis, By Type, 2020-2027
10.4.3.3 Market size analysis, By Deployment, 2020-2027
10.4.3.4 Market size analysis, By Solution, 2020-2027
10.4.3.5 Market size analysis, By Function, 2020-2027
10.4.4 South Africa
10.4.4.1 Market size analysis, By Product, 2020-2027
10.4.4.2 Market size analysis, By Type, 2020-2027
10.4.4.3 Market size analysis, By Deployment, 2020-2027
10.4.4.4 Market size analysis, By Solution, 2020-2027
10.4.4.5 Market size analysis, By Function, 2020-2027
10.4.5 Rest of LAMEA
10.4.5.1 Market size analysis, By Product, 2020-2027
10.4.5.2 Market size analysis, By Type, 2020-2027
10.4.5.3 Market size analysis, By Deployment, 2020-2027
10.4.5.4 Market size analysis, By Solution, 2020-2027
10.4.5.5 Market size analysis, By Function, 2020-2027
10.4.6 Research Dive Exclusive Insights
10.4.6.1 Market attractiveness
10.4.6.2 Competition heatmap
11. Competitive Landscape
11.1 Top winning strategies, 2020-2027
11.1.1 By strategy
11.1.2 By year
11.2 Strategic overview
11.3 Market share analysis, 2020-2027
12. Company Profiles
12.1 Accell Clinical Research, LLC
12.1.1 Overview
12.1.2 Business segments
12.1.3 Product portfolio
12.1.4 Financial performance
12.1.5 Recent developments
12.1.6 SWOT analysis
12.2 GenPact Ltd.
12.2.1 Overview
12.2.2 Business segments
12.2.3 Product portfolio
12.2.4 Financial performance
12.2.5 Recent developments
12.2.6 SWOT analysis
12.3 Criterium, Inc.
12.3.1 Overview
12.3.2 Business segments
12.3.3 Product portfolio
12.3.4 Financial performance
12.3.5 Recent developments
12.3.6 SWOT analysis
12.4 PRA Health Sciences
12.4.1 Overview
12.4.2 Business segments
12.4.3 Product portfolio
12.4.4 Financial performance
12.4.5 Recent developments
12.4.6 SWOT analysis
12.5 Promedica International
12.5.1 Overview
12.5.2 Business segments
12.5.3 Product portfolio
12.5.4 Financial performance
12.5.5 Recent developments
12.5.6 SWOT analysis
12.6 WuXiAppTec, Inc.
12.6.1 Overview
12.6.2 Business segments
12.6.3 Product portfolio
12.6.4 Financial performance
12.6.5 Recent developments
12.6.6 SWOT analysis
12.7 Medpace
12.7.1 Overview
12.7.2 Business segments
12.7.3 Product portfolio
12.7.4 Financial performance
12.7.5 Recent developments
12.7.6 SWOT analysis
12.8 Pharmaceutical Product Development, LLC
12.8.1 Overview
12.8.2 Business segments
12.8.3 Product portfolio
12.8.4 Financial performance
12.8.5 Recent developments
12.8.6 SWOT analysis
12.9 Charles River Laboratories International, Inc.
12.9.1 Overview
12.9.2 Business segments
12.9.3 Product portfolio
12.9.4 Financial performance
12.9.5 Recent developments
12.9.6 SWOT analysis
12.10 ICON plc
12.10.1 Overview
12.10.2 Business segments
12.10.3 Product portfolio
12.10.4 Financial performance
12.10.5 Recent developments
12.10.6 SWOT analysis
12.11 Covance, Parexel International Corporation
12.11.1 Overview
12.11.2 Business segments
12.11.3 Product portfolio
12.11.4 Financial performance
12.11.5 Recent developments
12.11.6 SWOT analysis
12.12 Inc.
12.12.1 Overview
12.12.2 Business segments
12.12.3 Product portfolio
12.12.4 Financial performance
12.12.5 Recent developments
12.12.6 SWOT analysis
12.13 Freyr.
12.13.1 Overview
12.13.2 Business segments
12.13.3 Product portfolio
12.13.4 Financial performance
12.13.5 Recent developments
12.13.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
